Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
Hikma’s USA subsidiary launches Zinecard generic, Dexrazoxane, for breast cancer
April 20, 2018 Off

Hikma’s USA subsidiary launches Zinecard generic, Dexrazoxane, for breast cancer

By Dino Mustafić

Hikma Pharmaceuticals has launched Dexrazoxane for Injection, 250mg and 500mg vials, the generic equivalent to Zinecard, through its US wholly-owned subsidiary…

Boehringer Ingelheim and HealthPrize Technologies expand RespiPoints digital support program
April 20, 2018 Off

Boehringer Ingelheim and HealthPrize Technologies expand RespiPoints digital support program

By Dino Mustafić

Boehringer Ingelheim and HealthPrize Technologies are expanding the RespiPoints digital support program to anyone taking one of several Boehringer Ingelheim…

Ultragenyx Pharmaceutical’s Crysvita first FDA-approved medication for the treatment of XLH
April 18, 2018 Off

Ultragenyx Pharmaceutical’s Crysvita first FDA-approved medication for the treatment of XLH

By Dino Mustafić

The U.S. Food and Drug Administration has approved Ultragenyx Pharmaceutical’s  Crysvita (burosumab), the first drug approved to treat adults and children ages…

Creso’s JV in launching of Global Beers and Tonics
April 18, 2018 Off

Creso’s JV in launching of Global Beers and Tonics

By Dino Mustafić

Creso Pharma said Wednesday that CLV Frontier Brands Pty, its equal one-third joint venture with UK-based Baltic Beer Company and…

Sanofi sells Zentiva for €1.9 billion
April 17, 2018 Off

Sanofi sells Zentiva for €1.9 billion

By Dino Mustafić

Sanofi has gotten an offer from Advent International, a global investor in healthcare sector, for purchase of Zentiva, Sanofi’s European…

Investigational gene therapy product Lymfactin for the treatment of secondary lymphedema tested in phase 1 study
April 16, 2018 Off

Investigational gene therapy product Lymfactin for the treatment of secondary lymphedema tested in phase 1 study

By Dino Mustafić

Herantis Pharma has gotten positive results from a safety evaluation in the ongoing Phase 1 clinical study of its investigational…

Telix Pharmaceuticals’s collaboration with INSERM and ARRONAX can deliver products for greater clinical utility to cancer patients
April 16, 2018 Off

Telix Pharmaceuticals’s collaboration with INSERM and ARRONAX can deliver products for greater clinical utility to cancer patients

By Dino Mustafić

Telix Pharmaceuticals, the specialist for radiopharmaceuticals or “molecularly-targeted radiation” (MTR), has entered into a research partnership with the French National…

Entresto helped preserve kidney function in patients with chronic heart failure
April 16, 2018 Off

Entresto helped preserve kidney function in patients with chronic heart failure

By Dino Mustafić

Novartis has announced a new post hoc analysis of the pivotal Phase III heart failure study, PARADIGM-HF, which showed that…

Sanofi investing €350 million for new vaccine factory in Canada
April 12, 2018 Off

Sanofi investing €350 million for new vaccine factory in Canada

By Dino Mustafić

Sanofi is investing €350 million for the construction of a new vaccine manufacturing facility at the Sanofi Pasteur Canadian headquarters…

Alexion buys Wislon Therapeutics for $855 Million
April 11, 2018 Off

Alexion buys Wislon Therapeutics for $855 Million

By Dino Mustafić

Alexion has offered to buy shares in a Stockholm-based biopharmaceutical company Wilson Therapeutics, which develops novel therapies for patients with…

Posts pagination

Previous 1 … 3,392 3,393 3,394 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine